Aurobindo Pharma Limited (AUROPHARMA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Aurobindo Pharma Limited (NSE: AUROPHARMA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 200, NIFTY 500, NIFTY Healthcare Index. As of 14 Nov 2026, the share price was ₹1,823.00, P/E 25.8, ROE 10.1%.
Get the AI verdict on AUROPHARMA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
AUROPHARMA chart with trendlines
Is AUROPHARMA a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Aurobindo Pharma Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
AUROPHARMA key facts
| Price and valuation | |
|---|---|
| Share price | ₹1,823.00 |
| Market cap | ₹1.05L Cr |
| P/E ratio | 25.8 |
| P/B ratio | 2.66 |
| EPS | ₹69.05 |
| Book value per share | ₹685.00 |
| Dividend yield | 0.38% |
| 52-week range | |
| 52-week high | ₹1,859.90 |
| 52-week low | ₹1,106.00 |
| Face value | ₹1.00 |
| Shareholding pattern | |
| Promoters | 51.88% |
| FIIs | 17.41% |
| DIIs | 24.37% |
| Public | 6.29% |
Index membership: NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 100, NIFTY Midcap 150, NIFTY Midcap 50, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.